Western Health Advantage
Zejula (niraparib)
Drugs for Cancer : Drugs for Cancer
  • Diabetes Type 2: GLP1 + Combo:
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A

  • QL (720 per 365 days; 120 per dispense);
  • Quantity Limit: limit maximum 30 EA PER 30 day(s)
  • Quantity Limit: 34g (2 bottles) per month